Neurocarrus Inc.
Monterey, CA · Biotech · Private
N-001, an engineered protein therapeutic that selectively targets sensory neurons to modulate actin cytoskeleton and reduce nociceptive pain
- Grants
- $6.0M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Selective actin remodeling of sensory neurons for acute pain management | $245,417 | |
| Federal grant | Department of Health and Human Services · Phase I · Selective actin remodeling of sensory neurons for acute pain management | $245,417 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Selective actin remodeling of sensory neurons for acute pain management | $2,776,138 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Selective actin remodeling of sensory neurons for acute pain management | $2,776,138 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1574 | GENELUX Corp | — | $24M |
| 1575 | RUMI SCIENTIFIC, INC. | — | — |
| 1576 | Max Biopharma, Inc. | — | — |
| 1577 | Neurocarrus Inc. | — | — |
| 1578 | ANOVAC, INC. | — | — |
| 1579 | Vesalius Therapeutics | — | — |
| 1580 | Immunova Therapeutics LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions And Methods For Treating And Preventing Headachesapplication
- Compositions And Methods For Treating And Preventing Headachesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.